NO20060832L - Behandling av aspirin resistens med radix salvie miltiorrhiaze, dens ekstrakt og sammensetning - Google Patents

Behandling av aspirin resistens med radix salvie miltiorrhiaze, dens ekstrakt og sammensetning

Info

Publication number
NO20060832L
NO20060832L NO20060832A NO20060832A NO20060832L NO 20060832 L NO20060832 L NO 20060832L NO 20060832 A NO20060832 A NO 20060832A NO 20060832 A NO20060832 A NO 20060832A NO 20060832 L NO20060832 L NO 20060832L
Authority
NO
Norway
Prior art keywords
treatment
miltiorrhiaze
sage
radix
extract
Prior art date
Application number
NO20060832A
Other languages
English (en)
Other versions
NO335203B1 (no
Inventor
Xijun Yan
Naifeng Wu
Zhengliang Ye
Xu Li
Zhixin Guo
Jun Zheng
Na Zhao
Original Assignee
Tianjin Tasly Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34621020&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20060832(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from CNB031552757A external-priority patent/CN100391486C/zh
Priority claimed from CNB2004100198381A external-priority patent/CN100411641C/zh
Application filed by Tianjin Tasly Pharmaceutical filed Critical Tianjin Tasly Pharmaceutical
Publication of NO20060832L publication Critical patent/NO20060832L/no
Publication of NO335203B1 publication Critical patent/NO335203B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/537—Salvia (sage)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/326—Foods, ingredients or supplements having a functional effect on health having effect on cardiovascular health

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Foreliggende oppfirmelse angår behandling av aspirinresistente kardiocerebrovaskulære sykdonmier ved bruk av RSM (RSM), dets ekstrakter og sammensetninger omfattende et hvilket som helst av dem eller begge, spesielt formuleringen Dan Shen drop-piller (Drpo-piller av RSM).
NO20060832A 2003-08-28 2006-02-21 Behandling av aspirin resistens med radix salvie miltiorrhiaze, dens ekstrakt og sammensetning. NO335203B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CNB031552757A CN100391486C (zh) 2003-08-28 2003-08-28 复方丹参滴丸在制备治疗阿司匹林抵抗性心血管疾病的药物中的应用
CNB2004100198381A CN100411641C (zh) 2004-06-30 2004-06-30 一种滴丸剂在制备治疗阿司匹林抵抗药物中的应用
PCT/CN2004/000989 WO2005049058A1 (fr) 2003-08-28 2004-08-26 Radix salviae miltiorrhizae, extrait et composition destines au traitement des maladies de resistance a l'aspirine

Publications (2)

Publication Number Publication Date
NO20060832L true NO20060832L (no) 2006-02-21
NO335203B1 NO335203B1 (no) 2014-10-20

Family

ID=34621020

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20060832A NO335203B1 (no) 2003-08-28 2006-02-21 Behandling av aspirin resistens med radix salvie miltiorrhiaze, dens ekstrakt og sammensetning.

Country Status (14)

Country Link
US (2) US20070071837A1 (no)
EP (1) EP1658879B1 (no)
JP (1) JP2007504099A (no)
KR (1) KR101210405B1 (no)
AU (1) AU2004290484B8 (no)
CA (1) CA2537300C (no)
DK (1) DK1658879T3 (no)
EA (1) EA010910B1 (no)
ES (1) ES2405599T3 (no)
HK (1) HK1092090A1 (no)
MY (1) MY143282A (no)
NO (1) NO335203B1 (no)
PT (1) PT1658879E (no)
WO (1) WO2005049058A1 (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1699475B1 (en) * 2003-11-07 2012-05-09 BASF Beauty Care Solutions S.A.S. Cosmetic use of an extract of the fruit of schisandra chinensis
MY147497A (en) * 2005-10-12 2012-12-14 Government Of Malaysia As Represented By The Ministry Of Science Technology And Innovation Malaysia Process for preparation of labisia pumila extract
GB2439046B (en) * 2006-06-16 2010-12-08 Phynova Ltd Antiviral product
JP5755633B2 (ja) * 2009-03-30 2015-07-29 タスリー・ファーマシューティカル・グループ・カンパニー・リミテッドＴａｓｌｙ Ｐｈａｒｍａｃｅｕｔｉｃａｌ Ｇｒｏｕｐ Ｃｏ．， Ｌｔｄ． 新規サルビアノール酸化合物ｌ、その調製方法及び使用
US20120148685A1 (en) * 2009-06-10 2012-06-14 Engergy4Life AG Methods and compositions for treating insulin resistance, diabetes mellitus type 2, metabolic syndrome and related disorders
CN102160872A (zh) * 2010-02-23 2011-08-24 天津天士力制药股份有限公司 复方丹参滴丸胶囊
MY172154A (en) * 2012-08-29 2019-11-14 Biotropics Malaysia Berhad Composition for cognition and cosmetic purposes and use of said composition for preparing an agent
CN103099896B (zh) * 2013-01-06 2014-10-01 车艳艳 治疗心脑血管疾病的药茶
CN103169777B (zh) * 2013-02-07 2014-09-10 江苏七○七天然制药有限公司 一种治疗心血管疾病的中药胶囊

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9104286D0 (en) * 1991-02-28 1991-04-17 Phytopharm Ltd Pharmaceutical compositions for the treatment of skin disorders
WO2001031052A1 (en) * 1999-10-25 2001-05-03 Colorado Coagulation Consultants Thromboxane b2 metabolite and methods for regulating aspirin-related platelet action
JP2001354579A (ja) * 2000-06-15 2001-12-25 Lion Corp 抗炎症化粧料
US8486464B2 (en) * 2000-12-22 2013-07-16 Tasly Pharmaceutical Group Co. Ltd. Herbal composition for angina pectoris, method to prepare same and uses thereof
EP1351698B1 (en) * 2000-12-22 2013-01-23 Tasly Pharmaceutical Group Co., Ltd. Herbal composition for angina pectoris, method to prepare same and uses thereof
US20050037094A1 (en) * 2003-07-31 2005-02-17 Xijun Yan Composition for heart disease, its active ingredients, method to prepare same and uses thereof

Also Published As

Publication number Publication date
PT1658879E (pt) 2013-04-08
AU2004290484B8 (en) 2010-05-13
JP2007504099A (ja) 2007-03-01
US20080305189A1 (en) 2008-12-11
HK1092090A1 (en) 2007-02-02
MY143282A (en) 2011-04-15
ES2405599T3 (es) 2013-05-31
CA2537300C (en) 2013-07-30
WO2005049058A1 (fr) 2005-06-02
EP1658879A4 (en) 2008-11-26
EA200600471A1 (ru) 2006-08-25
DK1658879T3 (da) 2013-05-13
WO2005049058A8 (fr) 2005-08-11
NO335203B1 (no) 2014-10-20
EP1658879A1 (en) 2006-05-24
EA010910B1 (ru) 2008-12-30
EP1658879B1 (en) 2013-02-20
CA2537300A1 (en) 2005-06-02
US20070071837A1 (en) 2007-03-29
KR20070017944A (ko) 2007-02-13
AU2004290484B2 (en) 2010-03-25
AU2004290484A1 (en) 2005-06-02
KR101210405B1 (ko) 2012-12-10

Similar Documents

Publication Publication Date Title
NO20060832L (no) Behandling av aspirin resistens med radix salvie miltiorrhiaze, dens ekstrakt og sammensetning
NO20060978L (no) Farmasoytiske blandingr for behandling av prematur ejakulasjon ved pulmonal inhalering
NO20064584L (no) Tetrahydropyridoindolderivater
WO2007095316A3 (en) Compositions and methods for oligonucleotide formulations
NO20064347L (no) Substituerte 1,2,3,4-tetrahydroisokinolinderivater
ATE304368T1 (de) Kräuterpflanzen enthaltende artzneimittel
DK1556021T3 (da) Farmaceutiske sammensætninger omfattende flavonoider og menthol samt fremgangsmåder til behandling med brug af nævnte sammensætninger
NO20075069L (no) Vaksiner mot Clamydia infeksjon
WO2007024949A3 (en) Alpha2c adrenoreceptor agonists
CL2007003061A1 (es) Compuestos derivados de 3,5-dioxi-benzamida; proceso de preparacion; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar una enfermedad mediada a traves de glk, tal como la diabetes tipo 2.
EP1708719A4 (en) AQUEOUS PHARMACEUTICAL COMPOSITIONS OF 2,6-DIISOPROPYLPHENOL (PROPOFOL) AND THEIR USE
CL2004000303A1 (es) Compuestos derivados de pirimidinas y triazinas; proceso de preparacion; composicion farmaceutica; y su uso para inhibir la replicacion del vih.
MEP27408A (en) Use of gpr119 receptor agonists for increasing bone mass and for treating osteoporosis, and combination therapy relating thereto
NO20050290L (no) Nye tetrahydropyridin-derivater som renin-inhibitorer
WO2006032091A3 (en) Herbal composition
WO2007133721A3 (en) Food compositions and methods of treating periodontal disease
WO2007020382A3 (en) Plant-based medicament for the treatment of liver disease
WO2008106979A3 (en) Pharmaceutical compositions comprising flavonoids and xylitol
FR2895251B1 (fr) Composition cosmetique comprenant au moins un poly(vinyllactame) cationique, au moins un alcool gras et au moins une silicone aminee, procede de traitement cosmetique et utilisation de la composition
WO2018025080A3 (en) Compositions for enhancing brain activity
EP1845928A4 (en) HERB MIXTURE EXTRACT FROM NOTOGINSENG RADIX, REHMANNIAE RADIX PREPARATA AND ACANTHOPANACIS CORTEX AND COMPOSITION THEREOF FOR THE PREVENTION AND TREATMENT OF ARTHRITIS
WO2007134118A3 (en) Protein based composition and methods of using same
EP1900372A8 (en) Composition for enhancing male fertility
WO2006090198A8 (en) Plant extracts and methods and uses therefore
NO20070186L (no) Sammensetninger inneholdende nicorandil, fremstillingsfremgangsmate og anvendelse av sammensetningen

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: TASLY PHARMACEUTICAL GROUP CO LTD, CN

MM1K Lapsed by not paying the annual fees